TY - JOUR T1 - Looking back on 60 years of <em>DTB</em>: antihypertensive drugs in 1962 JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull DO - 10.1136/dtb.2022.000029 SP - dtb-2022-000029 A2 - , Y1 - 2022/05/23 UR - http://dtb.bmj.com/content/early/2022/05/23/dtb.2022.000029.abstract N2 - This year, Drug and Therapeutics Bulletin (DTB) is celebrating its 60th anniversary and to mark this occasion we are looking back at some of DTB’s early articles.When DTB was first launched in 1962 there were no drug licensing laws, no formal controls of drug promotion or arrangements for pharmacovigilance, no summaries of product characteristics, and little recognition of the importance of scientific evidence to clinical practice.1 Doctors and drug companies went essentially unquestioned and there was little discussion with patients over details of their illness, treatment options or preferences.At a time when there were very few independent sources of reliable information on the effects of medicines, DTB’s aim was—and continues to be—‘to provide clinicians with clear, reliable, usable, impartial and independent information to help ensure patients get the best deal’.1In one of its early … ER -